肝疾患診断薬市場レポート：2030年までの動向、予測、競合分析

肝疾患診断薬の動向と予測

世界の肝疾患診断市場は、2024年から2030年までのCAGRが6.2%で、2030年までに推定505億米ドルに達すると予測されます。この市場の主な促進要因は、肝疾患の有病率の増加、アルコール消費量の増加、患者の正確かつ早期診断のための研究開発への支出の増加です。世界の肝疾患診断薬市場の将来は、病院市場や研究施設市場におけるビジネスチャンスによって有望視されています。

肝疾患診断市場の洞察

Lucintelは、肝疾患診断市場の主要企業が先進的な画像診断技術を開発するためのイニシアチブを多数とっていることから、予測期間中、画像診断が最大のセグメントであり続けると予測しています。

この市場では、入院患者の増加、高度な診断製品の入手可能性、十分な訓練を受けた看護スタッフの存在により、病院が引き続き最大セグメントとなります。

アジア太平洋は、ヘルスケア支出の増加、高齢者人口の増加、定期検診に対する意識の高まりにより、予測期間中に最も高い成長が見込まれています。

本レポートでは、以下の11の主要な質問に回答している：

• Q.1.市場セグメントのうち、最も有望かつ高成長な機会は何か？
• Q.2.どのセグメントがより速いペースで成長するのか、またその理由は？
• Q.3.今後成長が加速すると思われる地域とその理由は？
• Q.4.市場力学に影響を与える主な要因は何か？市場における主な課題とビジネスリスクは？
• Q.5.この市場におけるビジネスリスクと競合の脅威は？
• Q.6.この市場における新たな動向とその理由は？
• Q.7.市場における顧客の需要の変化にはどのようなものがありますか？
• Q.8.この市場における新たな開発と、その開発をリードしている企業は？
• Q.9.この市場における主要企業は？主要企業は事業成長のためにどのような戦略的取り組みを進めているのか？
• Q.10.この市場における競合製品にはどのようなものがあり、材料や製品の代替による市場シェア低下の脅威はどの程度ありますか？
• Q.11.過去5年間にどのようなM&Aが行われ、業界にどのような影響を与えましたか？

目次

第1章 エグゼクティブサマリー

第2章 世界の肝疾患診断市場：市場力学

• イントロダクション、背景、分類
• サプライチェーン
• 業界の促進要因と課題

第3章 2018年から2030年までの市場動向と予測分析

• マクロ経済動向（2018～2023年）と予測（2024～2030年）
• 世界の肝疾患診断市場動向（2018～2023年）と予測（2024～2030年）
• 診断技術別の世界の肝疾患診断市場
  • イメージング
  • 臨床検査
  • 内視鏡検査
  • 生検
  • その他
• 最終用途別の世界の肝疾患診断市場
  • 病院
  • 研究室
  • その他

第4章 2018年から2030年までの地域別の市場動向と予測分析

• 地域別の世界の肝疾患診断市場
• 北米の肝疾患診断市場
• 欧州の肝疾患診断市場
• アジア太平洋地域の肝疾患診断市場
• その他地域肝疾患診断市場

第5章 競合の分析

• 製品ポートフォリオ分析
• 運用上の統合
• ポーターのファイブフォース分析

第6章 成長機会と戦略的分析

• 成長機会分析
  • 診断技術別の世界の肝疾患診断市場の成長機会
  • 最終用途別の世界の肝疾患診断市場の成長機会
  • 地域別の世界の肝疾患診断市場の成長機会
• 世界の肝疾患診断市場の新たな動向
• 戦略的分析
  • 新製品の開発
  • 世界の肝疾患診断市場の能力拡大
  • 世界の肝疾患診断市場における合併、買収、合弁事業
  • 認証とライセンシング

第7章 有力企業の企業プロファイル

• Abbott
• F. Hoffmann-La Roche
• Thermo Fisher Scientific
• Randox Laboratories
• Boston Scientific Corporation
• Laboratory Corporation of America Holdings
• Fujifilm Corporation
• Horiba Medical
• Siemens Healthcare

Liver Disease Diagnostics Trends and Forecast

The future of the global liver disease diagnostics market looks promising with opportunities in the hospital and laboratoy markets. The global liver disease diagnostics market is expected to reach an estimated $50.5 billion by 2030 with a CAGR of 6.2% from 2024 to 2030. The major drivers for this market are increasing prevalence of liver diseases, rising alcohol consumption, and growing expenditure on research and development for accurate and early diagnosis of patients.

A more than 150-page report is developed to help in your business decisions.

Liver Disease Diagnostics by Segment

The study includes a forecast for the global liver disease diagnostics by diagnosis technique, end use, and region.

Liver Disease Diagnostics Market by Diagnosis Technique [Shipment Analysis by Value from 2018 to 2030]:

• Imaging
• Laboratory tests
• Endoscopy
• Biopsy
• Others

Liver Disease Diagnostics Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

• Hospitals
• Laboratories
• Others

Liver Disease Diagnostics Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Liver Disease Diagnostics Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies liver disease diagnostics companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the liver disease diagnostics companies profiled in this report include-

• Abbott
• F. Hoffmann-La Roche
• Thermo Fisher Scientific
• Randox Laboratories
• Boston Scientific Corporation
• Laboratory Corporation Of America Holdings
• Fujifilm Corporation
• Horiba Medical
• Siemens Healthcare

Liver Disease Diagnostics Market Insights

Lucintel forecasts that imaging will remain the largest segment over the forecast period due to the growing number of initiatives taken by key players in the market for liver disease diagnostics so as to develop advanced imaging techniques.

Within this market, hospitals will remain the largest segment due to growing admission of patient, availability of advanced diagnostic products, and presence of well-trained nursing staff.

APAC is expected to witness highest growth over the forecast period due to increasing healthcare expenditure, growing geriatric population, and rising awarness towards regular checkups in the region.

Features of the Global Liver Disease Diagnostics Market

Market Size Estimates: Liver disease diagnostics market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Liver disease diagnostics market size by diagnosis technique, end use, and region. in terms of value ($B).

Regional Analysis: Liver disease diagnostics market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different diagnosis techniques, end uses, and region.s for the liver disease diagnostics market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the liver disease diagnostics market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1. What is the liver disease diagnostics market size?

Answer: The global liver disease diagnostics market is expected to reach an estimated $50.5 billion by 2030.

Q.2. What is the growth forecast for liver disease diagnostics market?

Answer: The global liver disease diagnostics market is expected to grow with a CAGR of 6.2% from 2024 to 2030.

Q.3. What are the major drivers influencing the growth of the liver disease diagnostics market?

Answer: The major drivers for this market are increasing prevalence of liver diseases, rising alcohol consumption, and growing expenditure on research and development for accurate and early diagnosis of patients.

Q.4. What are the major segments for liver disease diagnostics market?

Answer: The future of the liver disease diagnostics market looks promising with opportunities in the hospitals and laboratories markets.

Q.5. Who are the key liver disease diagnostics market companies?

Answer: Some of the key liver disease diagnostics companies are as follows:

• Abbott
• F. Hoffmann-La Roche
• Thermo Fisher Scientific
• Randox Laboratories
• Boston Scientific Corporation
• Laboratory Corporation of America Holdings
• Fujifilm Corporation
• Horiba Medical
• Siemens Healthcare

Q.6. Which liver disease diagnostics market segment will be the largest in future?

Answer: Lucintel forecasts that imaging will remain the largest segment over the forecast period due to the growing number of initiatives taken by key players in the market for liver disease diagnostics so as to develop advanced imaging techniques.

Q.7. In liver disease diagnostics market, which region is expected to be the largest in next 5 years?

Answer: APAC is expected to witness highest growth over the forecast period due to increasing healthcare expenditure, growing geriatric population, and rising awarness towards regular checkups in the region.

Q.8. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the liver disease diagnostics market by diagnosis technique (imaging, laboratory tests, endoscopy, biopsy, and others), end use (hospitals, laboratories, and others), and region. (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Liver Disease Diagnostics Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Liver Disease Diagnostics Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Liver Disease Diagnostics Market by Diagnosis Technique
  • 3.3.1: Imaging
  • 3.3.2: Laboratory tests
  • 3.3.3: Endoscopy
  • 3.3.4: Biopsy
  • 3.3.5: Others
• 3.4: Global Liver Disease Diagnostics Market by End Use
  • 3.4.1: Hospitals
  • 3.4.2: Laboratories
  • 3.4.3: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Liver Disease Diagnostics Market by Region
• 4.2: North American Liver Disease Diagnostics Market
  • 4.2.2: North American Liver Disease Diagnostics Market by End Use: Hospitals, Laboratories, and Others
• 4.3: European Liver Disease Diagnostics Market
  • 4.3.1: European Liver Disease Diagnostics Market by Diagnosis Technique: Imaging, Laboratory Tests, Endoscopy, Biopsy, and Others
  • 4.3.2: European Liver Disease Diagnostics Market by End Use: Hospitals, Laboratories, and Others
• 4.4: APAC Liver Disease Diagnostics Market
  • 4.4.1: APAC Liver Disease Diagnostics Market by Diagnosis Technique: Imaging, Laboratory Tests, Endoscopy, Biopsy, and Others
  • 4.4.2: APAC Liver Disease Diagnostics Market by End Use: Hospitals, Laboratories, and Others
• 4.5: ROW Liver Disease Diagnostics Market
  • 4.5.1: ROW Liver Disease Diagnostics Market by Diagnosis Technique: Imaging, Laboratory Tests, Endoscopy, Biopsy, and Others
  • 4.5.2: ROW Liver Disease Diagnostics Market by End Use: Hospitals, Laboratories, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Liver Disease Diagnostics Market by Diagnosis Technique
  • 6.1.2: Growth Opportunities for the Global Liver Disease Diagnostics Market by End Use
  • 6.1.3: Growth Opportunities for the Global Liver Disease Diagnostics Market by Region
• 6.2: Emerging Trends in the Global Liver Disease Diagnostics Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Liver Disease Diagnostics Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Liver Disease Diagnostics Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Abbott
• 7.2: F. Hoffmann-La Roche
• 7.3: Thermo Fisher Scientific
• 7.4: Randox Laboratories
• 7.5: Boston Scientific Corporation
• 7.6: Laboratory Corporation of America Holdings
• 7.7: Fujifilm Corporation
• 7.8: Horiba Medical
• 7.9: Siemens Healthcare